Dihydromyricetin Alleviates Pulmonary Fibrosis by Regulating Abnormal Fibroblasts Through the STAT3/p-STAT3/GLUT1 Signaling Pathway

Background: Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive disorder with a poor prognosis. Although dihydromyricetin (DHM), extracted from vine tea and other Ampelopsis species, has been proven to have anti-inflammatory and antioxidant functions, the effects of DHM on IPF remain un...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhen, Geng, Jing, Xie, Bingbing, He, Jiarui, Wang, Jing, Peng, Liang, Hu, Yinan, Dai, Huaping, Wang, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964100/
https://www.ncbi.nlm.nih.gov/pubmed/35359847
http://dx.doi.org/10.3389/fphar.2022.834604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964100/
https://www.ncbi.nlm.nih.gov/pubmed/35359847
http://dx.doi.org/10.3389/fphar.2022.834604

Ejemplares similares